MoneyWorks4Me

Aurobindo Pharma informs about analyst meet

04 Mar 2022 Evaluate
Aurobindo Pharma has informed that S. Subramanian, Chief Financial Officer of the Company, will be participating in virtual event of Goldman Sachs India Pharma and Healthcare Tour 2022 on March 7, 2022. No unpublished price sensitive information (UPSI) is intended to be discussed during the interactions. 

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..